Evidence map›Paper›PMID 27812135›Full record

ArticlePloS one2016

Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting Proteins.

Raphaële Thiébaut, Sophie Esmiol, Patrick Lecine, Batoul Mahfouz, Aurelie Hermant, Cendrine Nicoletti, Stephane Parnis, Julie Perroy, Jean-Paul Borg, Leigh Pascoe and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 207 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Identification ofPathogens (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Article
  8. MicroRNA 429 regulates the expression of CHMP5 in the inflammatory colitis and colorectal cancer cells.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Raphaële ThiébautUMR1149, INSERM et Université Paris Diderot-Sorbonne Paris-Cité, 75018, Paris, France.
Sophie EsmiolINRA, UMR866, DMEM, Université de Montpellier, Montpellier, France.
Patrick LecineAix Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, "Cell Polarity, Cell signaling and Cancer - Equipe labellisée Ligue Contre le Cancer", Marseille, France.
Batoul MahfouzUMR1149, INSERM et Université Paris Diderot-Sorbonne Paris-Cité, 75018, Paris, France.
Aurelie HermantAix Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, "Cell Polarity, Cell signaling and Cancer - Equipe labellisée Ligue Contre le Cancer", Marseille, France.
Cendrine NicolettiAix Marseille Université, Centrale Marseille, CNRS, ISM2 UMR7313, 13397, Marseille, France.
Stephane ParnisAix Marseille Université, Centrale Marseille, CNRS, ISM2 UMR7313, 13397, Marseille, France.
Julie PerroyCNRS, UMR-5203, Institut de Génomique Fonctionnelle, Montpellier, F-34094, France.
Jean-Paul BorgAix Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, "Cell Polarity, Cell signaling and Cancer - Equipe labellisée Ligue Contre le Cancer", Marseille, France.
Leigh PascoeFondation Jean Dausset, CEPH, Paris, France.
Jean-Pierre HugotUMR1149, INSERM et Université Paris Diderot-Sorbonne Paris-Cité, 75018, Paris, France.
Vincent OllendorffINRA, UMR866, DMEM, Université de Montpellier, Montpellier, France.
Centre National de la Recherche Scientifique · FRInserm · FRUniversité de Montpellier · FRFondation Jean Dausset-CEPH · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NOD2 contributes to the innate immune response and to the homeostasis of the intestinal mucosa. In response to its bacterial ligand, NOD2 interacts with RICK and activates the NF-κB and MAPK pathways, inducing gene transcription and synthesis of proteins required to initiate a balanced immune response. Mutations in NOD2 have been associated with an increased risk of Crohn's Disease (CD), a disabling inflammatory bowel disease (IBD). Because NOD2 signaling plays a key role in CD, it is important to further characterize the network of protein interacting with NOD2. Using yeast two hybrid (Y2H) screens, we identified new NOD2 interacting proteins (NIP). The primary interaction was confirmed by coimmunoprecipitation and/or bioluminescence resonance energy transfer (BRET) experiments for 11 of these proteins (ANKHD1, CHMP5, SDCCAG3, TRIM41, LDOC1, PPP1R12C, DOCK7, VIM, KRT15, PPP2R3B, and C10Orf67). These proteins are involved in diverse functions, including endosomal sorting complexes required for transport (ESCRT), cytoskeletal architecture and signaling regulation. Additionally, we show that the interaction of 8 NIPs is compromised with the 3 main CD associated NOD2 mutants (R702W, G908R and 1007fs). Furthermore, to determine whether these NOD2 protein partners could be encoded by IBD susceptibility genes, a transmission disequilibrium test (TDT) was performed on 101 single nucleotide polymorphisms (SNPs) and the main corresponding haplotypes in genes coding for 15 NIPs using a set of 343 IBD families with 556 patients. Overall this work did not increase the number of IBD susceptibility genes but extends the NOD2 protein interaction network and suggests that NOD2 interactome and signaling depend upon the NOD2 mutation profile in CD.

Indexed as

Protein Interaction MappingCell LineCrohn DiseaseHumansMacrophagesMutationNF-kappa BNod2 Signaling Adaptor ProteinPolymorphism, Single NucleotideNF-kappa BNod2 Signaling Adaptor Protein

Identifiers

PMID27812135
PMCPMC5094585
OpenAlexW2548039226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.